SEC Form 4 · accession 0001209191-17-001469
Horizon Pharma plc · HZNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Timothy P Walbert
Officer — Chairman, President and CEO · Director
Period of report
Jan 2, 2017
Accepted (ET)
Jan 4, 2017 · 6:57 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492426
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Jan 2, 2017 | M | 81,675 | $0.00 | A | 416,549 | D | |
| Ordinary SharesF2 | Jan 2, 2017 | F | 37,703 | $16.18 | D | 378,846 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F3 | — | Jan 2, 2017 | M | 32,175 | D | — | — | Ordinary Shares | 32,175 | 0 | D |
| Restricted Stock UnitsF1,F4 | — | Jan 2, 2017 | M | 49,500 | D | — | — | Ordinary Shares | 49,500 | 49,500 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.
- F2Reflects the net settlement of ordinary shares of the Issuer in connection with the vesting of restricted stock units.
- F3On January 2, 2013, the reporting person was granted 128,700 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
- F4On January 2, 2014, the reporting person was granted 198,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.